GRIFOLS, S.A.

GRF
Real-time Estimate Quote. Real-time Estimate  - 09/28 03:59:53 pm
8.985EUR -6.29%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows:
- products derived from plasma (77.3%): products for use by the pharmaceutical and biotechnology industries;
- diagnostic machines and reagents (14.9%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers;
- hospital products (2.4%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies;
- other (5.4%): primarily intermediate biological products and subcontracted manufacturing services.
Net sales are distributed geographically as follows: Spain (7.4%), European Union (11%), the United States and Canada (63.9%) and other (17.7%).

Number of employees : 23 245 people.
Sales per Business
20202021
Bioscience4 242.5079.4%3 814.9877.3%
Diagnostic775.8914.5%779.1115.8%
Bio Supplies224.094.2%225.774.6%
Hospital118.682.2%141.192.9%
Others31.990.6%39.620.8%
EUR in Million
Sales per region
20202021
United States and Canada3 599.7567.4%3 154.5563.9%
Rest of World905.8017%872.1217.7%
Rest of European Union495.329.3%544.0411%
Spain339.176.4%362.417.3%
EUR in Million
Managers
Name Title
Raimon Grifols Roura Joint Chief Executive Officer & Executive Director
Victor Grifols Deu Joint Chief Executive Officer & Executive Director
Alfredo Arroyo Guerra Chief Financial Officer & Vice President
Víctor Grifols Roura Non-Executive Chairman
Xavier Sueiras Gil Chief Information Technology Officer
Marilyn Rosa-Bray Chief Medical Officer & Vice President-Quality
Antonio Martínez Martínez President-Diagnostic Scientific, R&D
César Cerezo Chief Medical Officer
Steven F. Mayer Independent Director
Belén Villalonga Morenés Independent Director
Shareholders
Name Equities %
Grifols Roura Family 39,183,692 9.20%
Scranton Enterprises BV 34,655,622 8.13%
Grifols Gras Family 30,209,093 7.09%
Ralledor Holding Spain SL 26,224,374 6.15%
Capital Research & Management Co. (World Investors) 20,172,660 4.73%
The Vanguard Group, Inc. 8,497,273 1.99%
Norges Bank Investment Management 7,422,333 1.74%
BlackRock Fund Advisors 7,189,748 1.69%
LGT Capital Partners AG (Investment Management) 6,713,280 1.58%
Jupiter Asset Management Ltd. 5,577,887 1.31%
Company contact information
Parc empresarial Can Sant Joan Avenida de la Generalitat 152
ES-08174 San Cugat del Vallés, Barcelona


Phone : +34 935712200
Fax : +34 938008000
web site : http://www.grifols.com
Markets and indexes
- Mercado Continuo
- IBEX 35 / PEA, STOXX Europe 600, Stoxx Spain 20
Stock Exchange Codes
- Bloomberg Code :  GRF:SM
- Reuters Code :  GRF.MC
Sector Biopharmaceuticals
1st jan.Capi. (M$)
GRIFOLS, S.A.-30.56%5 615
CSL LIMITED-2.09%88 434
SAMSUNG BIOLOGICS CO.,LTD.-15.06%37 595
BIOGEN INC.-17.56%28 702
WUXI BIOLOGICS (CAYMAN) INC.-47.16%26 568
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-32.25%19 595
BIOMARIN PHARMACEUTICAL INC.-5.56%15 476
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.-23.40%14 874
UCB-30.20%12 771
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED-14.36%8 984
WALVAX BIOTECHNOLOGY CO., LTD.-35.00%8 348
CELLTRION HEALTHCARE CO., LTD.-20.07%6 943
APELLIS PHARMACEUTICALS, INC.30.63%6 785
GRIFOLS, S.A.-43.18%5 615
SHANGHAI JUNSHI BIOSCIENCES CO., LTD.-57.93%5 539
SWEDISH ORPHAN BIOVITRUM AB (PUBL)13.18%5 496
INNOVENT BIOLOGICS, INC.-48.60%5 012
SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.-50.70%4 826
BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.-15.01%4 771
HUALAN BIOLOGICAL ENGINEERING INC.-38.40%4 655
SK BIOSCIENCE CO.,LTD.-61.42%4 583
Brand Portfolio
GRIFOLS
GRIFOLS
» More brands of Grifols, S.A.